Source: International Congress 2018 – Mechanisms of respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Riva (Milan, Italy), F. Gona (Milan, Italy), C. Cigana (Milan, Italy), M. Rossi (Milan, Italy), A. Esposito (Milan, Italy), T. Canu (Milan, Italy), A. Colarieti (Milan, Italy), A. Bragonzi (Milan, Italy), E. Tortoli (Milan, Italy), D. Cirillo (Milan, Italy). Characterization of murine model of chronic M. abscessus respiratory infection.. 2645

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Persistent M. tuberculosis infection: experimental model of endogenously re-activated TB Source: Eur Respir J 2002; 20: Suppl. 38, 582s Year: 2002 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001 Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018 Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016 Year: 2017 LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 On the nature of Mycobacterium tuberculosis-latent bacilli Source: Eur Respir J 2004; 24: 1044-1051 Year: 2004 Mycobacterium abscessus infection in lung transplant patients: review of our series Source: Annual Congress 2007 - Complications and success in lung transplantation Year: 2007 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018